Cross-Talk Between Thyroid Disorders and Nonalcoholic Fatty Liver Disease: From Pathophysiology to Therapeutics

被引：0
|
作者：
Yang, Yan [1 ]
Xiao, Jiyuan [2 ]
Qiu, Wen [2 ]
Jiang, Luxia [3 ]
机构：
[1] Lanzhou Univ Second Hosp, Dept Endocrinol & Metab, Lanzhou, Peoples R China
[2] Lanzhou Univ Second Hosp, Dept Pharmacol, Lanzhou, Peoples R China
[3] Lanzhou Univ Second Hosp, Dept Cardiac Surg ICU, Cuiyingmen 82, Lanzhou 730030, Peoples R China
来源：
HORMONE AND METABOLIC RESEARCH | 2024年 / 56卷 / 10期
基金：
中国国家自然科学基金;
关键词：
thyroid disorders; NAFLD; pathophysiology; therapeutics; RECEPTOR-BETA AGONISTS; HORMONE RECEPTOR; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; HEPATIC STEATOSIS; EXPRESSION; 3,5-DIIODO-L-THYRONINE; CHOLESTEROL; METABOLISM; ACTIVATION;
D O I：
10.1055/a-2276-7973
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The medical community acknowledges the presence of thyroid disorders and nonalcoholic fatty liver disease (NAFLD). Nevertheless, the interconnection between these two circumstances is complex. Thyroid hormones (THs), including triiodothyronine (T3) and thyroxine (T4), and thyroid-stimulating hormone (TSH), are essential for maintaining metabolic balance and controlling the metabolism of lipids and carbohydrates. The therapeutic potential of THs, especially those that target the TR beta receptor isoform, is generating increasing interest. The review explores the pathophysiology of these disorders, specifically examining the impact of THs on the metabolism of lipids in the liver. The purpose of this review is to offer a thorough analysis of the correlation between thyroid disorders and NAFLD, as well as suggest potential therapeutic approaches for the future.
引用
收藏
页码：697 / 705
页数：9
相关论文
共 50 条
  • [1] Cross-talk between the thyroid and liver:A new target for nonalcoholic fatty liver disease treatment
    Yue-Ye Huang
    Aaron M Gusdon
    Shen Qu
    World Journal of Gastroenterology, 2013, (45) : 8238 - 8246
  • [2] Cross-talk between the thyroid and liver: A new target for nonalcoholic fatty liver disease treatment
    Huang, Yue-Ye
    Gusdon, Aaron M.
    Qu, Shen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (45) : 8238 - 8246
  • [3] Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
    Polyzos, Stergios A.
    Kountouras, Jannis
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 92 : 82 - 97
  • [4] CROSS TALK BETWEEN THE LIVER MICROBIOME AND EPIGENOME IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Sookoian, Silvia C.
    Garaycoechea, Martin
    Pirola, Carlos Jose
    HEPATOLOGY, 2022, 76 : S78 - S79
  • [5] Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease
    Sunny, Nishanth E.
    Kalavalapalli, Srilaxmi
    Bril, Fernando
    Garrett, Timothy J.
    Nautiyal, Manisha
    Mathew, Justin T.
    Williams, Caroline M.
    Cusi, Kenneth
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2015, 309 (04): : E311 - E319
  • [6] Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk
    Nysather, Jacob
    Kaya, Eda
    Manka, Paul
    Gudsoorkar, Prakash
    Syn, Wing-Kin
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (04): : 315 - 335
  • [7] Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic steatohepatitis
    Manne, Vignan
    Handa, Priya
    Kowdley, Kris V.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 23 - +
  • [8] Cross-Talk between Insulin Resistance and FAT Atypical Cadherin 1 (FAT1) in Patients with Nonalcoholic Fatty Liver Disease
    Sookoian, Silvia C.
    Garaycoechea, Martin
    Gazzi, Carla
    Castano, Gustavo O.
    Flichman, Diego
    Pirola, Carlos J.
    HEPATOLOGY, 2018, 68 : 960A - 961A
  • [9] Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics
    Sookoian, Silvia
    Pirola, Carlos, I
    SEMINARS IN LIVER DISEASE, 2019, 39 (02) : 124 - 140
  • [10] Nonalcoholic Fatty Liver Disease Pathophysiology and Management
    Carr, Rotonya M.
    Oranu, Amanke
    Khungar, Vandana
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2016, 45 (04) : 639 - +
12345